Seerpharma.com.au :: Pharmaceutical Consulting & Training :: Validation, GMP & Compliance UK | Singapore | Korea

   

 

 

Congenital Heart Disease: Treatment

Description: Heart defects are the most common birth defect in the United States, occurring in about 1% of all live births, or a total of 40,000 newborns a year. Congenital Heart Disease (also termed Congenital Heart Defects) includes atrial and ventricular septal defects, patent ductus arteriosus, pulmonary stenosis and other valvular diseases, coarctation of the aorta, double outlet right ventricle, transposition of the great arteries, and hypoplastic left heart syndrome. This course presents treatment information about basic cardiovascular diseases, including coronary artery disease, coronary heart disease, valvular disease, and heart failure.

COURSE OUTLINE
INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview

PROGNOSIS AND TREATMENT
4. Objectives
5. Atrial and Ventricular Septal Defect
6. Patent Ductus Arteriosis
7. Valvular Diseases
8. Progress Check

PHARMACOLOGICAL THERAPIES
9. Objectives
10. ACE Inhibitors and ARBs
11. Beta Blockers
12. Diuretics
13. Digoxin
14. Vasodilators
15. Progress Check

CONCLUSION
16. Summary


COURSE OBJECTIVES
Students completing this course should be able to:
  • Differentiate between atrial septal defects and ventricular septal defects
  • Discuss the etiology and treatment of patent ductus arteriosis as well as valvular diseases
  • Explain why a congenital heart defect can lead to heart failure
  • Discuss treatment options for subsequent pathological conditions
  • Discuss the treatment of heart failure through the use of diuretics, cardiac glycosides, and vasodilators
  • Describe the use of antiarrhythmatics in controlling irregular heartbeats

 

   

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.

© SeerPharma Pty Ltd 2008 | Resources | Privacy Policy